Cite
HARVARD Citation
Abraham, A. et al. (2019). Early post-marketing experience with edaravone in an unselected group of patients with ALS. Amyotrophic lateral sclerosis and frontotemporal degeneration. 20 (3), pp. 260-263. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abraham, A. et al. (2019). Early post-marketing experience with edaravone in an unselected group of patients with ALS. Amyotrophic lateral sclerosis and frontotemporal degeneration. 20 (3), pp. 260-263. [Online].